• Je něco špatně v tomto záznamu ?

DORADA adherence study: full view into RebiSmart subdomains parameters in multiple sclerosis treatment

Z. Pavelek, M. Novotný, B. Klímová, M. Peterka, P. Potužník, M. Kövári, M. Vališ

. 2021 ; 37 (4) : 589-596. [pub] 20210213

Jazyk angličtina Země Velká Británie

Typ dokumentu klinické zkoušky, fáze IV, časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004482

PURPOSE: The aim of this article is to provide unique and detailed data on how patients rate the RebiSmart 2.0 in the specific User Study Questionnaire (USQ) domains, and the relationship between their rating and individual level of disability, baseline demographic/socioeconomic factors, and adherence. PATIENTS AND METHODS: Twelve-month, phase IV, observational, multicenter study (no placebo or comparator) to evaluate the ease of use of the RebiSmart autoinjector for self-injection during treatment of CIS/RRMS subjects with Rebif 44 mcg sc three times a week by USQ. A total of 290 subjects participated in the study, with 249 (85.86%) completing the entire study period. RESULTS: The endpoint results demonstrated a very high proportion (>95%) of patients with a positive evaluation of the overall convenience of RebiSmart at each study visit. At the end of the study, all patients would recommend the device to others who need Rebif therapy. The proportion of patients rating the RebiSmart ease of use by individual domains (self-injection steps, changing the cartridge, using the device away from home) as "very easy to use" or "easy to use" and the proportion of patients rating the RebiSmart functions as "helpful" or "very helpful" were more than 80% for each domain at each study visit. CONCLUSION: These findings are in line with the potential benefits of RebiSmart to treatment adherence. They demonstrate an overall, very good perception of the device by patients and its individual functions.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004482
003      
CZ-PrNML
005      
20220127145214.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/03007995.2021.1880886 $2 doi
035    __
$a (PubMed)33538199
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Pavelek, Zbyšek $u Department of Neurology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
245    10
$a DORADA adherence study: full view into RebiSmart subdomains parameters in multiple sclerosis treatment / $c Z. Pavelek, M. Novotný, B. Klímová, M. Peterka, P. Potužník, M. Kövári, M. Vališ
520    9_
$a PURPOSE: The aim of this article is to provide unique and detailed data on how patients rate the RebiSmart 2.0 in the specific User Study Questionnaire (USQ) domains, and the relationship between their rating and individual level of disability, baseline demographic/socioeconomic factors, and adherence. PATIENTS AND METHODS: Twelve-month, phase IV, observational, multicenter study (no placebo or comparator) to evaluate the ease of use of the RebiSmart autoinjector for self-injection during treatment of CIS/RRMS subjects with Rebif 44 mcg sc three times a week by USQ. A total of 290 subjects participated in the study, with 249 (85.86%) completing the entire study period. RESULTS: The endpoint results demonstrated a very high proportion (>95%) of patients with a positive evaluation of the overall convenience of RebiSmart at each study visit. At the end of the study, all patients would recommend the device to others who need Rebif therapy. The proportion of patients rating the RebiSmart ease of use by individual domains (self-injection steps, changing the cartridge, using the device away from home) as "very easy to use" or "easy to use" and the proportion of patients rating the RebiSmart functions as "helpful" or "very helpful" were more than 80% for each domain at each study visit. CONCLUSION: These findings are in line with the potential benefits of RebiSmart to treatment adherence. They demonstrate an overall, very good perception of the device by patients and its individual functions.
650    12
$a postižení $7 D006233
650    _2
$a lidé $7 D006801
650    _2
$a interferon beta 1a $x terapeutické užití $7 D000068556
650    12
$a roztroušená skleróza $x farmakoterapie $7 D009103
650    12
$a relabující-remitující roztroušená skleróza $x farmakoterapie $7 D020529
650    _2
$a autoaplikace $7 D012646
655    _2
$a klinické zkoušky, fáze IV $7 D017429
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Novotný, Michal $u Department of Neurology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Klímová, Blanka $u Department of Neurology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Peterka, Marek $u Department of Neurology, University Hospital Plzen, Plzen, Czech Republic
700    1_
$a Potužník, Pavel $u Department of Neurology, University Hospital Plzen, Plzen, Czech Republic
700    1_
$a Kövári, Martina $u Department of Rehabilitation and Sports Medicine, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
700    1_
$a Vališ, Martin $u Department of Neurology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
773    0_
$w MED00009520 $t Current medical research and opinion $x 1473-4877 $g Roč. 37, č. 4 (2021), s. 589-596
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33538199 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145210 $b ABA008
999    __
$a ok $b bmc $g 1751827 $s 1155631
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 37 $c 4 $d 589-596 $e 20210213 $i 1473-4877 $m Current medical research and opinion $n Curr Med Res Opin $x MED00009520
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...